Home ›› 21 May 2021 ›› World Biz

Covid: 4,209 more die in India, 2.59 lakh test positive

International Desk
21 May 2021 10:57:35 | Update: 21 May 2021 10:57:35
Covid: 4,209 more die in India, 2.59 lakh test positive
The infection rate has dropped to 12.58 per cent. - NDTV Photo

India on Friday reported 2.59 lakh new Covid-19 cases, taking its tally to 2.6 crore. The death count rose to 2,91,331 after 4,209 more patients died in the last 24 hours, reports NDTV.

Vaccinations showed a downward graph amid fears of a third wave in the next 6-8 months.

India, which has been reporting under three lakh daily cases for the last four days, is the second worst-hit country after the US. The positivity rate has dropped to 12.58 per cent.

Over 20.61 lakh samples were tested for the coronavirus infection in the last 24 hours till Friday morning, accounting for the highest single-day tests so far.

After Maharashtra, Karnataka, Kerala, Tamil Nadu and Uttar Pradesh have the highest number of infections in the country.

Delhi recorded 3,231 fresh cases of coronavirus and 233 fatalities in the last 24 hours. This was the second straight day the capital logged less than 4,000 cases. The positivity rate has dipped to 5.5 per cent. Chief Minister Arvind Kejriwal will take a call on lifting the lockdown over the weekend, after a discussion with Lieutenant Governor Anil Baijal.

More states ordered emergency measures to counter a surge in the rare deadly Black Fungus infection among recovered Covid patients. Odisha and Gujarat declared epidemics of Mucormycosis while the Delhi government said dedicated treatment centres for Black Fungus will be set up in three hospitals.

A seven-day rolling average of vaccinations in India showed an alarming decline for the seventh day on Thursday, as the Health Ministry said only 11.66 lakh people got their jabs a day ago, mounting concern about next waves of infections.

Bharat Biotech on Thursday said it plans to produce an additional 200 million (20 crore) doses of Covid-19 vaccine ''Covaxin'' at its subsidiary's Gujarat-based facility, taking the overall production volume of the vaccine to about 1 billion (100 crore) dosages per annum.

×